Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review

Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review

Saved in:

Bibliographic Details
Main Authors:	Jacob Itkin, Sudheer Dhoop, Thomas Sodeman
Format:	Article
Language:	English
Published:	The University of Toledo 2025-06-01
Series:	Translation
Subjects:	GLP-1RAs Diabetes Gastroparesis
Online Access:	http://openjournals.utoledo.edu/index.php/translation/article/view/1363
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
by: Xu He, et al.
Published: (2025-01-01)

Therapeutic potential of GLP-1RAs in sleep apnea with genetic associations to type 2 diabetes
by: Fang Cheng, et al.
Published: (2025-04-01)

Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
by: Andrew Overholser, et al.
Published: (2025-02-01)

Clarifying methodological approaches in the assessment of GLP-1 RAs and gastrointestinal cancer risk
by: Gisella Figlioli, et al.
Published: (2024-12-01)

Diabetic Gastroparesis Presenting with a Cyclic Vomiting Pattern
by: Yong Jin Nam, et al.
Published: (2017-09-01)

Pyloric botulinum toxin for diabetic gastroparesis: a case of sustained glycaemic improvement
by: Luke Bugeja, et al.
Published: (2025-07-01)

Association of GLP1RAs with risk of chronic obstructive pulmonary disease: evidence from drug target Mendelian randomization
by: Sijia Lai, et al.
Published: (2025-07-01)

Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment
by: Renjiao Liu, et al.
Published: (2025-07-01)

What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon‐like Peptide‐1 Receptor Agonists (GLP‐1 RAs)? A Scoping Review
by: Sam Febrey, et al.
Published: (2025-04-01)

Advances in GLP-1 receptor agonists for pain treatment and their future potential
by: Yongtao He, et al.
Published: (2025-02-01)

Current Concepts in Gastroparesis and Gastric Neuromuscular Disorders—Pathophysiology, Diagnosis, and Management
by: Jennifer Dimino, et al.
Published: (2025-04-01)

Efficacy of Itopride in Treatment of Gastroparesis Considering the State of Carbohydrate Metabolism in Patients with Type 2 Diabetes Mellitus
by: Kostitska I.
Published: (2015-12-01)

Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federation
by: O. K. Vikulova, et al.
Published: (2022-03-01)

Abdominal Pain and Chronic Opiate Use in Patients with Gastroparesis
by: Abraham Ifrah, et al.
Published: (2024-08-01)

Data mining–based analysis to explore the application of an animal model of diabetic gastroparesis
by: Hui Xu, et al.
Published: (2025-07-01)

Features of clinical presentation, diagnostics and treatment of idiopathic gastroparesis (<i>Review of literature and case presentation</i>)
by: Yu. V. Yevsyutina, et al.
Published: (2013-07-01)

Efficacy of GLP‐1 Receptor Agonist‐Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta‐Analysis of Randomized Controlled Trials
by: Yue Yin, et al.
Published: (2025-04-01)

From fluttering hearts to restless stomach: navigating atrial fibrillation, ablation and gastroparesis
by: Rabia Riasat, et al.
Published: (2025-06-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

Proposed Algorithm for the Diagnosis and Management of Diabetic Gastroparesis in the Indian Clinical Setting
by: Mohan V. G. Prasad, et al.
Published: (2025-05-01)

The potential biomarker value of soluble CD36 in the treatment of diabetic kidney disease: evidence from GLP-1 and insulin interventions
by: Wenxuan Li, et al.
Published: (2025-05-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

European Society for Neurogastroenterology and Motility Consensus on Gastroparesis: What Issues Remain Unresolved?
by: A. A. Sheptulin, et al.
Published: (2022-12-01)

Patients’ experiences with GLP1-RAs – a systematic review
by: Christoffer Kraul Ibsen, et al.
Published: (2025-04-01)

Long-term tuina can inhibit the occurrence of gastroparesis by protecting gastrointestinal function in diabetic rats
by: Jian-zhen Jiang, et al.
Published: (2025-06-01)

Gastroparesis and Systemic Lupus Erythematosus: A Propensity Score‐Matched Study of US National Database Analysis
by: Noppachai Siranart, et al.
Published: (2025-07-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Addressing the Shortage of GLP-1 RA and Dual GIP/GLP-1 RA-Based Therapies—A Systematic Review
by: Velimir Altabas, et al.
Published: (2025-06-01)

Prevalence of gastroparesis symptoms and its associated factors among type 2 diabetes mellitus patients in West Bank in Palestine: a national cross-sectional study
by: Diya Asad, et al.
Published: (2025-02-01)

Pan‐Alimentary Magnetic Resonance Imaging of Severe Gastroparesis May Facilitate Diagnosis and Treatment
by: Martin Longhi Engelbrecht, et al.
Published: (2024-11-01)

The healthcare burden imposed by children with gastroparesis and the shift imposed by COVID-19
by: Christian Sadaka, et al.
Published: (2025-07-01)

¿Combinamos AR-GLP1 + i-SGLT2? Sí o no
by: Claudia Folino
Published: (2024-10-01)

Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus
by: Alvin Hartanto Kurniawan, et al.
Published: (2019-11-01)

Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus
by: Alvin Hartanto Kurniawan, et al.
Published: (2019-11-01)

GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity
by: Vijay Kumar
Published: (2025-07-01)

Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
by: Lívia C. R. Teixeira, et al.
Published: (2025-01-01)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges
by: Francisco Westermeier, et al.
Published: (2025-01-01)

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Game Charger in the Field?
by: Georgia Doumani, et al.
Published: (2024-11-01)

The GLP-1 receptor agonist liraglutide inhibits necroptosis and neuroinflammation in a mouse model of Parkinson’s disease with diabetes co-morbidity
by: Xiaomin Zhang, et al.
Published: (2025-06-01)

Cardiovascular autonomic tests in diabetic patients with gastroparesis Testes autonômicos cardiovasculares em diabéticos com gastroparesia
by: Leila M.B. Araujo, et al.
Published: (1997-06-01)